The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...
The pharmaceutical industry is undergoing a profound transformation, driven by the increasing complexity of drug development and the need for greater efficiency and cost-effectiveness. At the heart of ...
Digital transformation to the Pharma 4.0 paradigm moves forward in process development and clinical and commercial manufacturing. Pharmaceutical manufacturers should be familiar with the terms “Smart ...
The pharmaceutical contract manufacturing market is driven by increased outsourcing of complex processes to CMOs, enabling ...
Manufacturing deals saw an unusual burst of recent activity, with a spike in the number of CDMOs acquiring facilities from pharma companies.
The "Contract Manufacturing in Pharmaceutical Industry, 2015 - 2025" report provides an extensive study of the rapidly growing pharmaceutical contract manufacturing market. With pharmaceutical and ...
Drug production is expected to be one of the main drivers of employment growth in U.S. manufacturing through 2034, with the ...
(MENAFN- IMARC Group) Setting up a pharmaceutical manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, ...
One of the trends that has emerged from the COVID-19 pandemic is the onshoring of U.S. pharmaceutical manufacturing. As more companies focus on manufacturing in the U.S., they face stringent ...
Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results